checkAd

    Evaxion Announces Phase 2 Clinical Trial Update  109  0 Kommentare First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01 - Seite 3 

    CONTACT: Contact Information  
Evaxion Biotech A/S 
Christian Kanstrup         
Chief Executive Officer 
cka@evaxion-biotech.com  
Source: Evaxion Biotech


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3
    Verfasst von globenewswire
    Evaxion Announces Phase 2 Clinical Trial Update First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01 - Seite 3 Significant Phase 2 clinical trial progress obtained with first patient finalizing EVX-01 vaccine dosingFavorable safety profile confirmedTrial on track for one-year clinical efficacy readout in Q3 2024 COPENHAGEN, Denmark, April 17, 2024 (GLOBE …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer